CV Sciences, Inc. (CVSI)
OTCMKTS: CVSI · Delayed Price · USD
0.0440
+0.0054 (13.84%)
May 3, 2024, 3:58 PM EDT - Market closed
CV Sciences Revenue
In the year 2023, CV Sciences had annual revenue of $16.00M, a decrease of -1.24%. Revenue in the quarter ending December 31, 2023 was $3.80M, a -1.76% decrease year-over-year.
Revenue (ttm)
$16.00M
Revenue Growth
-1.24%
P/S Ratio
0.45
Revenue / Employee
$381,048
Employees
42
Market Cap
7.18M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
Dec 31, 2020 | 24.43M | -29.27M | -54.50% |
Dec 31, 2019 | 53.70M | 5.45M | 11.30% |
Dec 31, 2018 | 48.24M | 27.56M | 133.30% |
Dec 31, 2017 | 20.68M | 9.62M | 86.96% |
Dec 31, 2016 | 11.06M | -468.77K | -4.07% |
Dec 31, 2015 | 11.53M | 1.34M | 13.14% |
Dec 31, 2014 | 10.19M | 8.04M | 373.09% |
Dec 31, 2013 | 2.15M | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.33B |
CVSI News
- 5 weeks ago - CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results - PRNewsWire
- 5 weeks ago - CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews - PRNewsWire
- 6 weeks ago - CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024 - PRNewsWire
- 5 months ago - CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution - PRNewsWire
- 6 months ago - CV Sciences, Inc. Reports Third Quarter 2023 Financial Results - PRNewsWire
- 6 months ago - CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023 - PRNewsWire
- 8 months ago - CV Sciences, Inc. Launches Reserve Sleep Gummies - PRNewsWire
- 9 months ago - CV Sciences, Inc. Reports Second Quarter 2023 Financial Results - PRNewsWire